Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $9.70, but opened at $10.36. Teladoc Health shares last traded at $10.01, with a volume of 2,335,899 shares changing hands.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on TDOC shares. Evercore ISI lifted their target price on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Royal Bank of Canada raised their price target on Teladoc Health from $9.00 to $10.00 and gave the company an "outperform" rating in a report on Wednesday, October 9th. Barclays raised their target price on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. Piper Sandler reaffirmed an "overweight" rating and set a $13.00 price target (up from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. Finally, Jefferies Financial Group boosted their price objective on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a "hold" rating in a report on Tuesday, September 17th. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $12.24.
Check Out Our Latest Stock Report on Teladoc Health
Teladoc Health Price Performance
The company has a 50 day moving average of $9.99 and a 200 day moving average of $9.03. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of -1.62 and a beta of 1.01.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. As a group, equities research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.
Insider Transactions at Teladoc Health
In related news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.95% of the company's stock.
Hedge Funds Weigh In On Teladoc Health
A number of hedge funds have recently made changes to their positions in TDOC. Connor Clark & Lunn Investment Management Ltd. increased its holdings in Teladoc Health by 15.5% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider's stock valued at $15,617,000 after purchasing an additional 228,004 shares in the last quarter. Clearline Capital LP grew its stake in shares of Teladoc Health by 395.6% in the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock valued at $42,682,000 after buying an additional 3,483,665 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock valued at $932,000 after buying an additional 63,028 shares during the period. Jennison Associates LLC acquired a new position in Teladoc Health during the 3rd quarter worth approximately $1,544,000. Finally, Massachusetts Financial Services Co. MA boosted its holdings in Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider's stock worth $3,397,000 after acquiring an additional 305,961 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
